actuary, ageing, alzheimer's disease, annuity (european), climate resilience, covid-19 pandemic in the united kingdom, crispr, defined benefit pension plan, defined contribution plan, dignity, economic inequality, gene therapy, health, insurance, old age, progress, quality of life, rights, social inequality, sustainability, sustainable development, sustainable development goals, world economic forum
President & Chief Executive Officer at OrphoMed, Inc.
actuary, ageing, alzheimer's disease, annuity (european), climate resilience, covid-19 pandemic in the united kingdom, crispr, defined benefit pension plan, defined contribution plan, dignity, economic inequality, gene therapy, health, insurance, old age, progress, quality of life, rights, social inequality, sustainability, sustainable development, sustainable development goals, world economic forum
Managing Director at Greater Asian Advisors Limited
actuary, ageing, alzheimer's disease, annuity (european), climate resilience, covid-19 pandemic in the united kingdom, crispr, defined benefit pension plan, defined contribution plan, dignity, economic inequality, gene therapy, health, insurance, old age, progress, quality of life, rights, social inequality, sustainability, sustainable development, sustainable development goals, world economic forum
President at Association of Asia Pacific Business Schools
actuary, ageing, alzheimer's disease, annuity (european), climate resilience, covid-19 pandemic in the united kingdom, crispr, defined benefit pension plan, defined contribution plan, dignity, economic inequality, gene therapy, health, insurance, old age, progress, quality of life, rights, social inequality, sustainability, sustainable development, sustainable development goals, world economic forum
actuary, ageing, alzheimer's disease, annuity (european), climate resilience, covid-19 pandemic in the united kingdom, crispr, defined benefit pension plan, defined contribution plan, dignity, economic inequality, gene therapy, health, insurance, old age, progress, quality of life, rights, social inequality, sustainability, sustainable development, sustainable development goals, world economic forum
Professor & Chair, Department of Biomedical Informatics at Harvard Medical School
aaai 20, aaai conference, adalimumab, ai, ai in medicine, ai research, alternative medicine, artificial intelligence in healthcare, biomarker, crispr, data, deep learning, dinosaur, dna sequencing, emv, gene, gene knock-in, genome editing, harvard university, health informatics, health information technology, inflammatory bowel disease, influenza, isaac kohane, leaf, machine learning, medical diagnosis, medicine ai, mutation, operating system, pay for performance (healthcare), pharmacovigilance, reinforcement learning, satan, simulation, startup company, trial and error, undiagnosed diseases network, wgn-tv
We use cookies on this website to enhance your browsing experience, measure our audience, and to collect information useful to provide you with more relevant content. By continuing to use this website, by closing this box, or by clicking here, you are indicating your consent to our use of cookies.